Already popular in the analysis of medical device trials adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseases and conditions from Alzheimerâs disease and multiple sclerosis to obesity diabetes hepatitis C and HIV. Written by leading pioneers of Bayesian clinical trial designs Bayesian Adaptive Methods for Clinical Trials explores the growing role of Bayesian thinking in the rapidly changing world of clinical trial analysis. The book first summarizes the current state of clinical trial design and analysis and introduces the main ideas and potential benefits of a Bayesian alternative. It then gives an overview of basic Bayesian methodological and computational tools needed for Bayesian clinical trials. With a focus on Bayesian designs that achieve good power and Type I error the next chapters present Bayesian tools useful in early (Phase I) and middle (Phase II) clinical trials as well as two recent Bayesian adaptive Phase II studies: the BATTLE and ISPY-2 trials. In the following chapter on late (Phase III) studies the authors emphasize modern adaptive methods and seamless Phase IIâIII trials for maximizing information usage and minimizing trial duration. They also describe a case study of a recently approved medical device to treat atrial fibrillation. The concluding chapter covers key special topics such as the proper use of historical data equivalence studies and subgroup analysis. For readers involved in clinical trials research this book significantly updates and expands their statistical toolkits. The authors provide many detailed examples drawing on real data sets. The R and WinBUGS codes used throughout are available on supporting websites. Scott Berry talks about the book on the CRC Press YouTube Channel. . Language: English